Theradaptive
PrivateLast Round
Series B
Aug 4, 2026
Total Funding Raised
$49.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Theradaptive is a biotechnology company that develops a protein therapeutics platform designed to enable targeted delivery of recombinant proteins for applications in spine, orthopedics, soft tissue repair, and immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theradaptive Comparables
Compare Theradaptive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RevBio, Inc. | 81% | |
| Locate Bio | 80% | |
| Cerapedics | 80% | |
Theradaptive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2026 | ||||
| Series B | Jan 12, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | May 22, 2024 | ||||
| Grant | Sep 26, 2023 | ||||
Grant | Jul 6, 2023 |
Key People
Founding team and executive leadership
Theradaptive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Grant |
| U.S. Department of War | Grant |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2026
Raised $36.2M in an early stage VC round.
- Oct 2, 2025
Received funding from the Maryland Stem Cell Research Fund.
Theradaptive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theradaptive's valuation, stock price, and market status.